UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For
the quarterly period ended
For the transition period from _______ to _______
Commission
file number:
(Exact name of registrant as specified in its charter)
(State of incorporation) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Names of each exchange on which registered | ||
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: There were a total of shares of Common Stock outstanding as of August 10, 2021.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large Accelerated Filer ☐ | Accelerated Filer ☐ | |
| Smaller
Reporting Company |
Emerging
Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
TABLE OF CONTENTS
| i |
Cautionary Note Regarding Forward Looking Statements
This Quarterly Report on Form 10-Q as well as our other public filings or public statements include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by terms and phrases such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” and “will” and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies.
These forward-looking statements involve known and unknown risks, assumptions and uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements. These risks, assumptions and uncertainties include difficulty in marketing Reed’s products and services, maintaining and protecting brand recognition, the need for significant capital, dependence on third party distributors, dependence on third party brewers, increasing costs of fuel and freight, protection of intellectual property, competition and other factors, any of which could have an adverse effect on the business plans of Reed’s, its reputation in the industry or its expected financial return from operations and results of operations. These risks, assumptions and uncertainties are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements.
We undertake no obligation to update or revise the forward-looking statements included in this report, whether as a result of new information, future events or otherwise, after the date of this report. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.
| ii |
Part I – FINANCIAL INFORMATION
Item 1. Financial Statements
REED’S INC.
CONDENSED BALANCE SHEETS
(Amounts in thousands, except share amounts)
June 30, 2021 | December 31, 2020 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable, net of allowance of $ | ||||||||
| Receivable from related party | ||||||||
| Inventory, net of reserve of $ | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net of accumulated depreciation of $ | ||||||||
| Equipment held for sale, net of impairment reserves of $ | ||||||||
| Intangible assets | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Payable to related party | ||||||||
| Accrued expenses | ||||||||
| Revolving line of credit | - | |||||||
| Current portion of note payable | - | |||||||
| Current portion of leases liabilities | ||||||||
| Total current liabilities | ||||||||
| Leases liabilities, less current portion | ||||||||
| Note payable, less current portion | - | |||||||
| Total liabilities | ||||||||
| Stockholders’ equity: | ||||||||
| Series A Convertible Preferred stock, $ par value, shares authorized, shares issued and outstanding | ||||||||
| Common stock, $ par value, shares authorized, and shares issued and outstanding, respectively | ||||||||
| Additional paid in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ | ||||||
The accompanying notes are an integral part of these condensed financial statements.
| F-1 |
REED’S, INC.
CONDENSED STATEMENTS OF OPERATIONS
For the Three and Six Months Ended June 30, 2021 and 2020
(Unaudited)
(Amounts in thousands, except share and per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net Sales | $ | $ | $ | $ | ||||||||||||
| Cost of goods sold | ||||||||||||||||
| Gross profit | ||||||||||||||||
| Operating expenses: | ||||||||||||||||
| Delivery and handling expense | ||||||||||||||||
| Selling and marketing expense | ||||||||||||||||
| General and administrative expense | ||||||||||||||||
| Total operating expenses | ||||||||||||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Gain on extinguishment of PPP note payable | ||||||||||||||||
| Change in fair value of warrant liability | - | ( | ) | - | ( | ) | ||||||||||
| Net loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Dividends on Series A Convertible Preferred Stock | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net Loss Attributable to Common Stockholders | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Loss per share – basic and diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average number of shares outstanding – basic and diluted | ||||||||||||||||
The accompanying notes are an integral part of these condensed financial statements.
| F-2 |
REED’S, INC.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the Three and Six Months Ended June 30, 2021 and 2020
(Unaudited)
(Amounts in thousands except share amounts)
| Common Stock | Preferred Stock | Common Stock Issuable | Additional Paid In | Accumulated | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) | ||||||||||||||||||||||||||||
| Balance, March 31, 2021 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Fair value of vested options | - | - | - | |||||||||||||||||||||||||||||||||
| Fair value of vested restricted shares granted to an officer for services | ||||||||||||||||||||||||||||||||||||
| Issuance of shares for dividends on Series A Convertible Preferred Stock | - | - | - | ( | ) | ( | ) | |||||||||||||||||||||||||||||
| Repurchase of shares | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||
| Common shares issued on exercise of stock options | ||||||||||||||||||||||||||||||||||||
| Common shares issued pursuant to the rights offering, net of offering costs | - | - | - | - | ||||||||||||||||||||||||||||||||
| Net Loss | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||
| Balance, June 30, 2021 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Common Stock | Preferred Stock | Common Stock Issuable | Additional Paid In | Accumulated | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) | ||||||||||||||||||||||||||||
| Balance, December 31, 2020 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Fair value of vested options | - | - | ||||||||||||||||||||||||||||||||||
| Fair value of vested restricted shares granted to officers | - | - | - | - | ||||||||||||||||||||||||||||||||
| Issuance of shares for dividends on Series A Convertible Preferred Stock | - | - | - | ( | ) | ( | ) | |||||||||||||||||||||||||||||
| Repurchase of common stock | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||
| Common shares issued on exercise of options | - | |||||||||||||||||||||||||||||||||||
| Common shares issued for financing costs | ||||||||||||||||||||||||||||||||||||
| Common shares issued pursuant to the rights offering, net of offering costs | - | - | - | - | ||||||||||||||||||||||||||||||||
| Net Loss | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||
| Balance, June 30, 2021 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| F-3 |
| Common Stock | Preferred Stock | Common Stock Issuable | Additional Paid In | Accumulated | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) | ||||||||||||||||||||||||||||
| Balance, March 31, 2020 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||||||||
| Fair value of vested options | - | ( | ) | ( | ) | |||||||||||||||||||||||||||||||
| Dividends on Series A Convertible Preferred Stock | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||
| Common shares issued pursuant to the rights offering, net of offering costs | - | - | ||||||||||||||||||||||||||||||||||
| Net Loss | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||
| Balance, June 30, 2020 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Common Stock | Preferred Stock | Common Stock Issuable | Additional Paid In | Accumulated | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) | ||||||||||||||||||||||||||||
| Balance, December 31, 2019 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Fair value of vested options | ||||||||||||||||||||||||||||||||||||
| Fair value of vested restricted shares granted to an officer for services | ||||||||||||||||||||||||||||||||||||
| Dividends on Series A Convertible Preferred Stock | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||||||||||||||
| Common shares issued pursuant to the rights offering, net of offering costs | - | - | - | |||||||||||||||||||||||||||||||||
| Net Loss | - | ( | ) | ( | ) | |||||||||||||||||||||||||||||||
| Balance, June 30, 2020 | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these condensed financial statements.
| F-4 |
REED’S, INC.
CONDENSED STATEMENTS OF CASH FLOWS
For the Six Months Ended June 30, 2021 and 2020
(Unaudited)
(Amounts in thousands)
| June 30, 2021 | June 30, 2020 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | ||||||||
| Gain on termination of leases | ( | ) | ( | ) | ||||
| Gain on forgiveness of debt | ( | ) | - | |||||
| Amortization of debt discount | ||||||||
| Amortization of prepaid financing costs | - | |||||||
| Amortization of right of use assets | ||||||||
| Fair value of vested options | ||||||||
| Fair value of vested restricted shares granted to officers | ||||||||
| Common stock issued for services | - | - | ||||||
| Decrease in allowance for doubtful accounts | ( | ) | ( | ) | ||||
| Decrease (increase) in inventory reserve | ( | ) | ( | ) | ||||
| Change in fair value of warrant liability | - | |||||||
| Accrual of interest on convertible note to a related party | - | |||||||
| Lease liability | ( | ) | ( | ) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ||||||
| Inventory | ( | ) | ||||||
| Prepaid expenses and other assets | ( | ) | ( | ) | ||||
| Accounts payable | ( | ) | ( | ) | ||||
| Accrued expenses | ( | ) | ( | ) | ||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities: | ||||||||
| Trademark costs | ( | ) | ( | ) | ||||
| Proceeds from sale of property and equipment | - | - | ||||||
| Purchase of property and equipment | ( | ) | ( | ) | ||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Borrowings on line of credit | ||||||||
| Repayments of line of credit | ( | ) | ( | ) | ||||
| Proceeds from note payable | - | |||||||
| Repayment of amounts due to/from officers | - | |||||||
| Principal repayments on capital lease obligation | ( | ) | ( | ) | ||||
| Proceeds from exercise of stock options | - | |||||||
| Repurchase of common stock | ( | ) | - | |||||
| Proceeds from sale of common stock | ||||||||
| Net cash provided by financing activities | ||||||||
| Net increase in cash | ||||||||
| Cash at beginning of period | ||||||||
| Cash at end of period | $ | $ | ||||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | $ | ||||||
| Non Cash Investing and Financing Activities | ||||||||
| Dividends on Series A Convertible Preferred Stock | $ | $ | ||||||
The accompanying notes are an integral part of these condensed financial statements.
| F-5 |
REED’S, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Three and Six Months Ended June 30, 2021 and 2020 (Unaudited)
(In thousands, except share and per share amounts)
1. Basis of Presentation and Liquidity
The accompanying interim condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly our financial position at June 30, 2021 and the results of operations and cash flows for the three and six months ended June 30, 2021 and 2020. The balance sheet as of December 31, 2020 is derived from the Company’s audited financial statements.
Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. For further information, refer to the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 30, 2021.
The results of operations for the six months ended June 30, 2021 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2021.
COVID-19 Considerations
During the period ended June 30, 2021, the COVID-19 pandemic has impacted our operating results and the Company anticipates a continued impact for the balance of the year. In addition, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.
Through June 30, 2021, the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company believes that costs will continue to increase throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans are being implemented to manage this risk.
Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through June 30, 2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.
Net sales for the six month period ended June 30, 2021 were up 15% from the prior year period. Through June 30, 2021, we continue to generate cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.
Liquidity
The
accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption
contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the six months ended June
30, 2021, the Company recorded a net loss of $
| F-6 |
Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. We have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.
2. Significant Accounting Policies
Use of estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock compensation expense.
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied.
The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time.
All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.
The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.
Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive.
| F-7 |
June 30, 2021 | June 30, 2020 | |||||||
| Convertible note to a related party | ||||||||
| Warrants | ||||||||
| Common stock equivalent of Series A Convertible Preferred stock | ||||||||
| Common stock issuable | ||||||||
| Unvested restricted common stock | ||||||||
| Options | ||||||||
| Total | ||||||||
The Series A Convertible Preferred Stock is convertible into Common shares at the rate of 1:4.
The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.
The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.
Advertising Costs
Advertising
costs are expensed as incurred and are included in selling and marketing expense. Advertising costs for the three months ended June 30,
2021 and 2020, aggregated $
Concentrations
Sales.
During the three months ended June 30, 2021, two customers accounted
for
Accounts
receivable. As of June 30, 2021, the Company had accounts receivable from one customer which comprised
Purchases
from vendors. During the three months ended June 30, 2021, two vendors accounted for
| F-8 |
Accounts
payable. As of June 30, 2021, the Company’s four largest vendors accounted for
Fair Value of Financial Instruments
The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.
Level 3—Unobservable inputs based on the Company’s assumptions.
The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows.
In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).” ASU 2020-06 reduces the number of accounting models for convertible debt instruments by eliminating the cash conversion and beneficial conversion models. The diluted net income per share calculation for convertible instruments will require the Company to use the if-converted method. For contracts in an entity’s own equity, the type of contracts primarily affected by this update are freestanding and embedded features that are accounted for as derivatives under the current guidance due to a failure to meet the settlement conditions of the derivative scope exception. This update simplifies the related settlement assessment by removing the requirements to (i) consider whether the contract would be settled in registered shares, (ii) consider whether collateral is required to be posted, and (iii) assess shareholder rights. ASU 2020-06 is effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. Effective January 1, 2021, the Company early adopted ASU 2020-06 and that adoption did not have an impact on our financial statements and related disclosures.
Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
3. Inventory
Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, and net of reserves is comprised of the following (in thousands):
June 30, 2021 | December 31, 2020 | |||||||
| Raw materials and packaging | $ | $ | ||||||
| Finished products | ||||||||
| Total | $ | $ | ||||||
The
Company has recorded a reserve for slow moving and potentially obsolete inventory. The reserve at June 30, 2021, and December 31, 2020,
was $
| F-9 |
4. Property and Equipment
Property and equipment is comprised of the following (in thousands):
June 30, 2021 | December 31, 2020 | |||||||
| Right-of-use assets under operating leases | $ | $ | ||||||
| Right-of-use assets under finance leases | ||||||||
| Computer hardware and software | ||||||||
| Machinery and equipment | ||||||||
| Total cost | ||||||||
| Accumulated depreciation and amortization | ( | ) | ( | ) | ||||
| Net book value | $ | $ | ||||||
Depreciation
expense for the six months ended June 30, 2021 and 2020 was $
Equipment held for sale consists of the following (in thousands):
June 30, 2021 | December 31, 2020 | |||||||
| Equipment held for sale | $ | $ | ||||||
| Reserve | ( | ) | ( | ) | ||||
| Net book value | $ | $ | ||||||
The balance as of June 30, 2021, and December 31, 2020, consists of residual manufacturing equipment, at estimated net realizable value, which management anticipates selling during 2021.
5. Intangible Assets
Intangible
assets are comprised of brand names acquired, specifically Virgil’s, and costs related to trademarks. They have been assigned an
indefinite life, as we currently anticipate that they will contribute cash flows to the Company perpetually. These indefinite-lived intangible
assets are not amortized but are assessed for impairment annually and evaluated annually to determine whether the indefinite useful life
remains appropriate. We first assess qualitative factors to determine whether it is more likely than not that the asset is impaired.
If further testing is necessary, we compare the estimated fair value of our asset with its book value. If the carrying amount of the
asset exceeds its fair value, as determined by the discounted cash flows expected to be generated by the asset, an impairment loss is
recognized in an amount equal to that excess. Based on management’s assessment, there were
During
the six months ended June 30, 2021, the Company capitalized costs of $
Intangible assets consist of the following (in thousands):
June 30, 2021 | December 31, 2020 | |||||||
| Brand names | $ | $ | ||||||
| Trademarks | ||||||||
| Total | $ | $ | ||||||
| F-10 |
6. Line of Credit
Amounts outstanding under the Company’s credit facilities are as follows (in thousands):
June 30, 2021 | December 31, 2020 | |||||||
| Line of credit | $ | $ | ||||||
On
October 4, 2018, the Company entered into a financing agreement with Rosenthal & Rosenthal, Inc. (“Rosenthal”).
The financing agreement provides a maximum borrowing capacity of $
Borrowings
under the Rosenthal financing agreement bear interest at the greater of prime or
The
line of credit is secured by substantially all of the assets, excluding intellectual property, of the Company. The over-advance is secured
by all of Reed’s intellectual property collateral. Additionally, any over-advance was guaranteed by an irrevocable stand-by letter
of credit in the amount of $
John
J. Bello, current Chairman and former Interim Chief Executive Officer of Reed’s, is a related party. He is also a greater than
The financing agreement with Rosenthal includes customary restrictions that limit our ability to engage in certain types of transactions, including our ability to utilize tangible and intangible assets as collateral for other indebtedness. Additionally, the agreement contains a financial covenant that requires us to meet certain minimum working capital and tangible net worth thresholds as of the end of each quarter. We were in compliance with the terms of our agreement with Rosenthal as of June 30, 2021.
The
Company annually incurs an additional $
7. Note Payable
On
April 20, 2020, the Company was granted a loan (the “PPP loan”) from City National Bank in the aggregate amount of $
| F-11 |
8. Leases Liabilities
The Company accounts for leases under ASC 842, Leases. The standard requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease, initially measured at the present value of the lease payments.
ASC
842 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated
over the lease term, generally on a straight-line basis. During the six months ended June 30, 2021, the Company reflected amortization
of right of use asset of $
In accordance with ASC 842, the right-of-use assets are being amortized over the life of the underlying leases.
As
of December 31, 2020, lease liabilities totalled $
As
of June 30, 2021, the weighted average remaining lease terms for operating leases are
9. Common Stock
Common stock issuance
On
May 5, 2021, the Company entered into a placement agency agreement with Roth Capital Partners, LLC (the “Placement Agent”)
and a securities purchase agreement with a certain purchaser for the purchase of shares of the Company’s common stock, par value
$ per share, in an offering of securities registered under an effective registration statement filed with the Securities and Exchange
Commission (“SEC”). In the offering, the Company sold shares of common stock, at a price of $ per share. The
offering closed on May 7, 2021 and total proceeds received, net of fees, were $
Common stock repurchases
During
the six months ended June 30, 2021, the Company repurchased shares of common stock from an officer
for $
Restricted common stock
| Unvested Shares | Issuable Shares | Fair Value at Date of Issuance | Weighted Average Grant Date Fair Value | |||||||||||||
| Balance, December 31, 2020 | $ | |||||||||||||||
| Granted | ||||||||||||||||
| Vested | ( | ) | ||||||||||||||
| Forfeited | ( | ) | ||||||||||||||
| Issued | ( | ) | ( | ) | ||||||||||||
| Balance, June 30, 2021 | $ | $ | ||||||||||||||
On
January 26, 2021, the board of directors of Reed’s, pursuant to a joint recommendation from its governance and compensation committees,
set the cash compensation of its non-employee directors at $
| F-12 |
The
total fair value of vested restricted common stock vesting during the six months ended June 30, 2021 and 2020 was $
Stock options
| Shares | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Terms (Years) | Aggregate Intrinsic Value | |||||||||||||
| Outstanding at December 31, 2020 | $ | $ | ||||||||||||||
| Granted | $ | |||||||||||||||
| Exercised | ( | ) | $ | |||||||||||||
| Unvested forfeited | ( | ) | $ | |||||||||||||
| Vested forfeited | ( | ) | $ | |||||||||||||
| Outstanding at June 30, 2021 | $ | $ | ||||||||||||||
| Exercisable at June 30, 2021 | $ | $ | ||||||||||||||
During
the six months ended June 30, 2021, the Company received proceeds of $
During the six months ended June 30, 2021, the Company approved options exercisable into shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan. options were issued to employees, options vesting annually over a vesting period, and options that will vest based on performance criteria to be established by the board of directors.
The stock options are exercisable at prices ranging from $ to $ per share and expire in . The total fair value of these options at grant date was approximately $, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: stock price of $ per share, expected term of , volatility of %, dividend rate of %, and weighted average risk-free interest rate of %. The expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.
During the six months ended June 30, 2021 and 2020, the Company recognized $and $of compensation expense relating to vested stock options. As of June 30, 2021, the aggregate amount of unvested compensation related to stock options was approximately $which will be recognized as an expense as the options vest in future periods through March 28, 2025.
As of June 30, 2021, the outstanding and exercisable options have an intrinsic value of $ and $, respectively. The aggregate intrinsic value was calculated as the difference between the closing market price as of June 30, 2021, which was $, and the exercise price of the outstanding stock options.
| F-13 |
10. Stock Warrants
As of June 30, 2021, the Company has issued warrants to purchase an aggregate of 3,362,241 shares of common stock. The Company’s warrant activity during the six months ended June 30, 2021 is as follows:
| Shares | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Terms (Years) | Aggregate Intrinsic Value | |||||||||||||
| Outstanding at December 31, 2020 | $ | $ | ||||||||||||||
| Exercised | ||||||||||||||||
| Forfeited | ( | ) | $ | |||||||||||||
| Outstanding at June 30, 2021 | $ | $ | ||||||||||||||
| Exercisable at June 30, 2021 | $ | $ | ||||||||||||||
There
were warrant transactions during the six months ended June 30, 2021. As of June 30, 2021, the outstanding and exercisable warrants
have an intrinsic value of $
11. Related Party Activities
On
December 31, 2018, the Company completed the sale of its Los Angeles manufacturing plant to California Custom Beverage, LLC (“CCB”),
an entity owned by Christopher J. Reed, a related party, and CCB assumed the monthly payments on our lease obligation for the Los Angeles
manufacturing plant. Our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $
Beginning
in 2019, we are to receive a
At
December 31, 2020, the Company had an aggregate receivable balance from CCB of $
Any over-advance on the Company’s line of
credit with Rosenthal was guaranteed by an irrevocable stand-by letter of credit in the amount of $
John J. Bello, current Chairman and former Interim Chief Executive
Officer of Reed’s, is a related party. He is also a greater than
At
June 30, 2021 and December 31, 2020, the Company had accounts payable due to CCB of $
Lindsay
Martin, daughter of a director of the Company, is employed as Vice President of Marketing. Ms. Martin was paid approximately $
13. Subsequent Events
Subsequent to June 30, 2021, the Company issued shares of common stock on the exercise of stock options, and shares of common stock to its directors.
| F-14 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes appearing elsewhere in this report.
In addition to our GAAP results, the following discussion includes Modified EBITDA as a supplemental measure of our performance. We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.
The following discussion also includes the use of gross billing, a key performance indicator and metric. Gross billing represents invoiced amounts to distributors and retailers, excluding sales adjustments. Gross billing may include deductions from MSRP or “list price”, where applicable, and excludes promotional costs of generating such sales. Management utilizes gross billing to monitor operating performance of products and salespersons, which performance can be masked by the effect of promotional or other allowances. Management believes that the presentation of gross billing provides a useful measure of Reed’s operating performance.
Overview
During the second quarter of 2021, the Company fully utilized their expanded network of co-packers and continues to adhere to strict set of quality protocols. In addition to our traditional sales channels, the Company is expanding in the club, drug, convenience and ecommerce channels including their branded web sites and Amazon to offer its line of shots, ginger candy and drinks packaged in cans.
The Company remains focused on driving sales growth and improving margin. The sales growth focus is on channel expansion, new product introduction and improved sales execution. The margin enhancement initiative is driven by co-packer upgrades, better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs. However, the Company experienced elevated raw material and transportation costs over the prior year and anticipates these costs to remain elevated for the balance of the year. Plans have been developed to mitigate the impact of these costs.
COVID-19 Considerations
During the period ended June 30, 2021, the COVID-19 pandemic has impacted our operating results and the Company anticipates a continued impact for the balance of the year. In addition, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.
Through June 30, 2021, the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company believes that costs will continue to increase throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans are being implemented to manage this risk.
| 1 |
Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through June 30, 2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.
Net sales for the six months ended June 30, 2021 were up 15% from the prior year period. Through June 30, 2021, we continue to generate cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.
Results of Operations – Three months ended June 30, 2021
The following table sets forth key statistics for the three months ended June 30, 2021 and 2020, respectively, in thousands.
| Three Months Ended June 30, | Pct. | |||||||||||
| 2021 | 2020 | Change | ||||||||||
| Gross billing (A) | $ | 12,626 | $ | 12,229 | 3 | % | ||||||
| Less: Promotional and other allowances (B) | 1,356 | 1,376 | -1 | % | ||||||||
| Net sales | $ | 11,270 | $ | 10,853 | 4 | % | ||||||
| Cost of goods sold | 8,001 | 7,865 | 2 | % | ||||||||
| % of Gross billing | 63 | % | 64 | % | ||||||||
| % of Net sales | 71 | % | 72 | % | ||||||||
| Gross profit | $ | 3,269 | $ | 2,988 | 9 | % | ||||||
| % of Net sales | 29 | % | 28 | % | ||||||||
| Expenses | ||||||||||||
| Delivery and handling | $ | 2,508 | $ | 1,480 | 70 | % | ||||||
| % of Net sales | 22 | % | 14 | % | ||||||||
| Dollar per case ($) | 3.53 | 2.27 | ||||||||||
| Selling and marketing | 2,634 | 1,585 | 66 | % | ||||||||
| % of Net sales | 23 | % | 15 | % | ||||||||
| General and administrative | 1,836 | 1,357 | 35 | % | ||||||||
| % of Net sales | 16 | % | 12 | % | ||||||||
| Total operating expenses | 6,978 | 4,422 | 58 | % | ||||||||
| Loss from operations | $ | (3,709 | ) | $ | (1,434 | ) | 159 | % | ||||
| Interest expense and other income (expense) | 568 | (316 | ) | -279 | % | |||||||
| Net loss | $ | (3,141 | ) | $ | (1,750 | ) | 80 | % | ||||
| Loss per share – basic and diluted | $ | (0.03 | ) | $ | (0.03 | ) | 18 | % | ||||
| Weighted average shares outstanding - basic & diluted | 90,801,842 | 59,514,620 | 53 | % | ||||||||
(A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing has been defined by our internal reporting practices.
| 2 |
(B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. Although the expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.
Sales, Cost of Sales, and Gross Margins
The following chart sets forth key statistics for the transition of the Company’s top line activity from the second quarter of 2020 through the second quarter of 2021.
| 2021 | 2020 | Q2 Per Case | H1 Per Case | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Q1 | Q2 | H1 | Q2 vs PY | H1 vs PY | Q1 | Q2 | H1 | 2021 | 2020 | vs PY | 2021 | 2020 | vs PY | |||||||||||||||||||||||||||||||||||||||||||||
| Cases: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reed’s | 395 | 353 | 748 | 5 | % | 20 | % | 288 | 335 | 623 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Virgil’s | 339 | 347 | 686 | 13 | % | 20 | % | 262 | 308 | 570 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Total Core | 734 | 700 | 1,434 | 9 | % | 20 | % | 550 | 643 | 1,193 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Non Core | - | 2 | 2 | - | % | 0 | % | 2 | - | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Candy | 8 | 8 | 16 | 0 | % | 0 | % | 8 | 8 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 742 | 710 | 1,452 | 9 | % | 20 | % | 560 | 651 | 1,211 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Gross billing: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Core | $ | 12,955 | $ | 12,200 | $ | 25,155 | 2 | % | 14 | % | $ | 10,175 | $ | 11,940 | $ | 22,115 | $ | 17.4 | $ | 18.6 | -6 | % | $ | 17.5 | $ | 18.5 | -5 | % | ||||||||||||||||||||||||||||||
| Non Core | 33 | 140 | 173 | 324 | % | 28 | % | 102 | 33 | 135 | 70.0 | - | - | % | 86.4 | 67.5 | 28 | % | ||||||||||||||||||||||||||||||||||||||||
| Candy | 294 | 286 | 580 | 12 | % | 9 | % | 274 | 256 | 530 | 35.7 | 32.0 | 12 | % | 36.2 | 33.1 | 9 | % | ||||||||||||||||||||||||||||||||||||||||
| Total | $ | 13,281 | $ | 12,626 | $ | 25,907 | 3 | % | 14 | % | $ | 10,551 | $ | 12,229 | $ | 22,780 | $ | 17.8 | 18.8 | -5 | % | 17.8 | 18.8 | -5 | % | |||||||||||||||||||||||||||||||||
| Discounts: | Total | $ | (1,135 | ) | $ | (1,356 | ) | $ | (2,491 | ) | -1 | % | 4 | % | $ | (1,028 | ) | $ | (1,376 | ) | $ | (2,404 | ) | $ | (1.9 | ) | $ | (2.1 | ) | -9 | % | $ | (1.7 | ) | $ | (2.0 | ) | -13 4 | % | |||||||||||||||||||
| COGS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Core | $ | (8,122 | ) | $ | (7,849 | ) | $ | (15,971 | ) | 2 | % | 13 | % | $ | (6,414 | ) | $ | (7,674 | ) | $ | (14,088 | ) | $ | (11.2 | ) | $ | (11.9 | ) | -6 | % | $ | (11.1 | ) | $ | (11.8 | ) | -6 | % | ||||||||||||||||||||
| Non Core | (6 | ) | (6 | ) | (13 | ) | -57 | % | -83 | % | (59 | ) | (15 | ) | (74 | ) | (3.2 | ) | - | - | % | (6.4 | ) | (37.0 | ) | -83 | % | |||||||||||||||||||||||||||||||
| Candy | (165 | ) | (143 | ) | (308 | ) | -19 | % | -14 | % | (180 | ) | (176 | ) | (356 | ) | (17.8 | ) | (22.0 | ) | -19 | % | (19.2 | ) | (22.3 | ) | -14 | % | ||||||||||||||||||||||||||||||
| Total | $ | (8,293 | ) | $ | (7,998 | ) | $ | (16,291 | ) | 2 | % | 12 | % | $ | (6,653 | ) | $ | (7,865 | ) | $ | (14,518 | ) | $ | (11.3 | ) | $ | (12.1 | ) | -8 | % | $ | (11.2 | ) | $ | (12.0 | ) | -7 | % | ||||||||||||||||||||
| Gross Profit: | $ | 3,853 | $ | 3,260 | $ | 7,113 | 9 | % | 21 | % | $ | 2,870 | $ | 2,988 | $ | 5,858 | $ | 4.6 | $ | 4.6 | 0 | % | $ | 4.9 | $ | 4.8 | 1 | % | ||||||||||||||||||||||||||||||
| as % Net Sales | 32 | % | 29 | % | 30 | % | 30 | % | 28 | % | 29 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
Sales, Cost of Sales, and Gross Margins
As part of the Company’s ongoing initiative to simplify and streamline operations, the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of Wellness Shots, candy and slower selling discontinued Reed’s and Virgil’s SKUs.
Core beverage volume for the three months ended June 30, 2021, represents 99% of all beverage volume.
Core brand gross billing increased by 2% to $12,200 compared to the same period last year, driven by Reed’s volume growth of 5% and Virgil’s volume growth of 13%. The result is an increase in total gross billing of 3%, to $12,626 in the three months ended June 30, 2021, from $12,229 during the three months ended June 30, 2020. Price on our core brands decreased 6% to $17.43 per case due to a shift in mix to lower priced, higher margin products.
Discounts as a percentage of gross billing were 11% for the three months ended June 30, 2021 and 2020. Net sales revenue grew 4% in the three months ended June 30, 2021 to $11,270, compared to $10,853 in the same period last year.
Cost of Goods Sold
Cost of goods sold increased $136 during the three months ended June 30, 2021 as compared to the same period last year. As a percentage of net sales, cost of goods sold for the three months ended June 30, 2021 was 71% as compared to 72% for the same period last year.
The total cost of goods per case decreased to $11.27 per case in the three months ended June 30, 2021 from $12.08 per case for the same period last year. The cost of goods sold per case on core brands was $11.22 during the three months ended June, 2021, compared to $11.93 for the same period last year.
Gross Margin
Gross margin increased to 29% for the three months ended June 30, 2021, compared to 28% for the same period last year.
Operating Expenses
Delivery and Handling Expenses
Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses increased by $1,028 in the three months ended June 30, 2021 to $2,508 from $1,480 in the same period last year, driven by increased volumes, ecommerce fulfilment costs, and increasing freight rates due to Covid-19. Delivery costs in the three months ended June 30, 2021 were 22% of net sales and $3.53 per case, compared to 14% of net sales and $2.27 per case during the same period last year.
Selling and Marketing Expenses
Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $2,634 during the three months ended June 30, 2021, compared to $1,585 during the same period last year. As a percentage of net sales, selling and marketing costs increased to 23% during the three months ended June 30, 2021, as compared to 15% during the same period last year. The increase was driven by an increase in sales force headcount and stock compensation.
General and Administrative Expenses
General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses increased in the three months ended June 30, 2021 to $1,836 from $1,357, an increase of $479 over the same period last year. The increase was primarily driven by higher employee costs and stock compensation.
| 4 |
Loss from Operations
The loss from operations was $3,709 for the three months ended June 30, 2021, as compared to a loss of $1,434 in the same period last year driven by increased gross profit offset by increases in operating expenses discussed above.
Interest and Other Income (Expense)
Interest and other income for the three months ended June 30, 2021, consisted of $202 of interest expense offset by $770 gain on forgiveness of debt. During the same period last year, interest and other expense consisted of $303 of interest expense and by the change in fair value of our warrant liability of $13.
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.
Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended June 30, 2021 and 2020 (unaudited; in thousands):
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Net loss | $ | (3,141 | ) | $ | (1,750 | ) | ||
| Modified EBITDA adjustments: | ||||||||
| Depreciation and amortization | 61 | 37 | ||||||
| Interest expense | 202 | 303 | ||||||
| Stock option and other noncash compensation | 599 | (36 | ) | |||||
| Change in fair value of warrant liability | - | 13 | ||||||
| Gain on forgiveness of PPP note payable | (770 | ) | - | |||||
| Legal settlements | (8 | ) | - | |||||
| Total EBITDA adjustments | $ | 84 | $ | 317 | ||||
| Modified EBITDA | $ | (3,057 | ) | $ | (1,433 | ) | ||
| 5 |
We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:
| ● | Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; | |
| ● | Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs; | |
| ● | Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and | |
| ● | Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements. |
Results of Operations – Six months ended June 30, 2020
The following table sets forth key statistics for the six months ended June 30, 2021 and 2020, respectively, in thousands.
| Six Months Ended June 30, | Pct. | |||||||||||
| 2021 | 2020 | Change | ||||||||||
| Gross billing (A) | $ | 25,907 | $ | 22,781 | 14 | % | ||||||
| Less: Promotional and other allowances (B) | 2,491 | 2,405 | 4 | % | ||||||||
| Net sales | $ | 23,416 | $ | 20,376 | 15 | % | ||||||
| Cost of goods sold | 16,294 | 14,518 | 12 | % | ||||||||
| % of Gross billing | 63 | % | 64 | % | ||||||||
| % of Net sales | 70 | % | 71 | % | ||||||||
| Gross profit | $ | 7,122 | $ | 5,858 | 22 | % | ||||||
| % of Net sales | 30 | % | 29 | % | ||||||||
| Expenses | ||||||||||||
| Delivery and handling | $ | 5,795 | $ | 2,743 | 111 | % | ||||||
| % of Net sales | 25 | % | 13 | % | ||||||||
| Dollar per case ($) | 3.99 | 2.47 | ||||||||||
| Selling and marketing | 4,849 | 3,510 | 38 | % | ||||||||
| % of Net sales | 21 | % | 17 | % | ||||||||
| General and administrative | 4,439 | 3,289 | 35 | % | ||||||||
| % of Net sales | 19 | % | 16 | % | ||||||||
| Total operating expenses | 15,083 | 9,542 | 58 | % | ||||||||
| Loss from operations | $ | (7,961 | ) | $ | (3,684 | ) | 116 | % | ||||
| Interest expense and other income (expense) | 312 | (646 | ) | -148 | % | |||||||
| Net loss | $ | (7,649 | ) | $ | (4,330 | ) | 77 | % | ||||
| Loss per share – basic and diluted | $ | (0.09 | ) | $ | (0.08 | ) | 13 | % | ||||
| Weighted average shares outstanding - basic & diluted | 88,751,896 | 53,554,913 | 66 | % | ||||||||
(A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing have been defined by our internal reporting practices.
| 6 |
(B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.
Sales, Cost of Sales, and Gross Margins
As part of the Company’s ongoing initiative to simplify and streamline operations the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of Wellness Shots, candy and slower selling discontinued Reed’s and Virgil’s SKUs.
Core beverage volume for the six months ended June 30, 2021, represents 99% of all beverage volume.
Core brand gross billing increased by 14% to $25,155 compared to the same period last year, driven by Reed’s volume growth of 20% and Virgil’s volume growth of 20%. The result is an increase in total gross billing of 14%, to $25,907 in the six months ended June 30, 2021, from $22,781 during the six months ended June 30, 2020. Price on our core brands decreased 5% to $17.54 per case due to a shift in mix to lower priced, higher margin products.
Discounts as a percentage of gross billing decreased to 10% from 11% in the same period last year. As a result, net sales revenue grew 15% in the six months ended June 30, 2021 to $23,416, compared to $20,376 in the same period last year.
Cost of Goods Sold
Cost of goods sold increased $1,776 during the six months ended June 30, 2021 as compared to the same period last year. As a percentage of net sales, cost of goods sold for the six months ended June 30, 2021 was 70% as compared to 71% for the same period last year.
The total cost of goods per case decreased to $11.22 per case in the six months ended June 30, 2021 from $11.99 per case for the same period last year. The cost of goods sold per case on core brands was $11.14 during the six months ended June 30, 2021, compared to $11.81 for the same period last year.
Gross Margin
Gross margin was 30% for the six months ended June 30, 2021, compared to 29% for the same period last year.
| 7 |
Operating Expenses
Delivery and Handling Expenses
Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses increased by $3,052 in the six months ended June 30, 2021 to $5,795 from $2,743 in the same period last year, driven by increased volumes, ecommerce fulfilment costs, and increasing freight rates due to Covid-19. Delivery costs in the six months ended June 30, 2021 were 25% of net sales and $3.99 per case, compared to 13% of net sales and $2.27 per case during the same period last year.
Selling and Marketing Expenses
Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses increased $1,339 to $4,849 during the six months ended June 30, 2021, compared to $3,510 during the same period last year. As a percentage of net sales, selling and marketing costs increased to 21% during the six months ended June 30, 2021, as compared to 17% during the same period last year. The increase was driven by an increase in sales force headcount and stock compensation.
General and Administrative Expenses
General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses increased in the six months ended June 30, 2021 to $4,439 from $3,289 an increase of $1,150 over the same period last year. The increase was driven by legal settlements, employee costs, stock compensation, consulting fees, and public company costs.
Loss from Operations
The loss from operations was $7,961 for the six months ended June 30, 2021, as compared to a loss of $3,684 in the same period last year driven by increased gross profit offset by increases in operating expenses discussed above.
Interest and Other Income (Expense)
Interest and other income for the six months ended June 30, 2021, consisted of $458 of interest expense offset by $770 gain on forgiveness of debt. During the same period last year, interest and other expense consisted of $639 of interest expense and the change in fair value of our warrant liability of $7.
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.
Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
| 8 |
Set forth below is a reconciliation of net loss to Modified EBITDA for the six months ended June 30, 2021 and 2020 (unaudited; in thousands):
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Net loss | $ | (7,649 | ) | $ | (4,330 | ) | ||
| Modified EBITDA adjustments: | ||||||||
| Depreciation and amortization | 118 | 86 | ||||||
| Interest expense | 458 | 639 | ||||||
| Stock option and other noncash compensation | 997 | 744 | ||||||
| Change in fair value of warrant liability | - | 7 | ||||||
| Gain on forgiveness of PPP note payable | (770 | ) | - | |||||
| Legal settlements | 345 | - | ||||||
| Total EBITDA adjustments | $ | 1,148 | $ | 1,476 | ||||
| Modified EBITDA | $ | (6,501 | ) | $ | (2,854 | ) | ||
We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:
| ● | Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; | |
| ● | Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs; | |
| ● | Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and | |
| ● | Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements. |
Liquidity and Capital Resources
The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
For the six months ended June 30, 2021, the Company recorded a net loss of $7,649 and used cash in operations of $10,309. As of June 30, 2021, we had a cash balance of $654 with borrowing capacity of $4,343, a stockholder’s equity of $11,566 and a working capital of $10,470, compared to a cash balance of $595 with borrowing capacity of $5,166, stockholders’ equity of $10,404 and a working capital of $9,528 at December 31, 2020. Notwithstanding the net loss for the six months ended June 30, 2021, management projects adequate cash from operations and available line of credit to ensure continuation of the Company as a going concern for at least one year from the date of this quarterly report.
| 9 |
Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. We have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.
Critical Accounting Policies and Estimates
Use of Estimates and Assumptions. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivables, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.
Accounts Receivable. Accounts receivable are recorded at the invoiced amounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding.
Inventory. Inventory is stated at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and our ability to sell the product(s) concerned. Demand for our products can fluctuate significantly. Factors that could affect demand for our products include unanticipated changes in consumer preferences, general market conditions or other factors, which may result in cancellations of advance orders or a reduction in the rate of reorders placed by customers. Additionally, our management’s estimates of future product demand may be inaccurate, which could result in an understated or overstated provision required for excess and obsolete inventory.
Revenue Recognition. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer.
Stock Compensation Expense. The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.
Recent Accounting Pronouncements
See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
A smaller reporting company is not required to provide the information required by this Item.
| 10 |
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of June 30, 2021, to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the three months ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
We are subject to various legal proceedings from time to time in the ordinary course of business, none of which are required to be disclosed under this Item 1.
Item 1A. Risk Factors
In addition to the following risk factors and the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part I, Item 1A of our Annual Report on Form 10-K (our Form 10-K) for the year ended December 31, 2020 and any subsequent filings with the Securities and Exchange Commission (SEC) made prior to the date hereof, which could materially affect our business, financial condition, results of operations or future results. The risks and uncertainties discussed below, in our Form 10-K and in any subsequent filings with the SEC made prior to the date hereof are not the only ones facing our business. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially adversely affect our business, cash flows, financial condition and/or results of operations. The risk factor below updates, and should be read together with, the risk factors disclosed in Part I, Item 1A of our Form 10-K. Please also read the Cautionary Notice Regarding Forward-Looking Statements and Information in Part I, Item 2 of this Quarterly Report on Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
Increases in costs of freight may have an adverse impact on our gross and operating margins.
The capacity in the freight market has not kept up with demand and increased freight rates. During the six months ended June 30, 2021, we experienced higher transportation expenses. We believe that costs will continue to increase throughout fiscal 2021. We are implementing mitigation plans to manage this risk; however, due to the price sensitivity of our products, we may not be able to pass such increases on to our customers. For a discussion of increased delivery and handling expenses, see “Operating Expenses” under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part I, Item 2 of this Form 10-Q.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None that have not been previously disclosed in a Current Report on Form 8-K.
Item 3. Defaults Upon Senior Securities
None.
| 11 |
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits
| Exhibit | Filed | Incorporated by Reference | ||||||||||
| No. | Exhibit Title | Herewith | Form | Exhibit | File No. | Date Filed | ||||||
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||||||||
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||||||||
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||||||||
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||||||||
| 101.INS | XBRL Instance Document | X | ||||||||||
| 101.SCH | XBRL Taxonomy Extension Schema Document | X | ||||||||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||
| 101.DEF | XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||
| 101.LAB | XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||
| 101.PRE | XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||
In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.
Furnished herewith, XBRL (Extensive Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
| 12 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Reed’s, Inc. (Registrant) | |
| Date: August 12, 2021 | /s/ Norman E. Snyder, Jr. |
| Norman E. Snyder, Jr. | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| Date: August 12, 2021 | /s/ Thomas J. Spisak |
| Thomas J. Spisak | |
| Chief Financial Officer | |
| (Principal Financial Officer) |
| 13 |